PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 08/26/2019

Pipeline Type

New Drugs in Development

Phase Of Development

Phase 2

Sponsors and Collaborators

Actelion (J&J company) / Idorsia Pharmaceuticals Ltd.

Mechanism of Action

Ion Channel

Mechanism Description

Selective T-type Calcium Channel Blocker

Populations Tested In

Photosensitive epilepsy

Special FDA Designation

Nonprofit or Government Support

N/A

Nonprofit or Government Support Description

N/A

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A

Location of Clinical Trials

France / Germany

Join Our Newsletter

Want to get notified about new devices? Stay up to date with the latest epilepsy news and stories from the community.